Menu Search
Equities

SpectraCure AB (publ)

2OK:DEU

SpectraCure AB (publ)

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year SpectraCure AB (publ) has grown net income from a loss of -25.38m to a smaller loss of -20.44m despite declining revenues.
Gross margin442.39%
Net profit margin-895.85%
Operating margin-917.34%
Return on assets-14.82%
Return on equity-16.50%
Return on investment-15.91%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at SpectraCure AB (publ) fell by 36.23m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 18.68m for operations while cash used for investing totalled 15.56m.
Cash flow per share-0.1914
Price/Cash flow per share--
Book value per share1.21
Tangible book value per share0.3238
More ▼

Balance sheet in SEKView more

SpectraCure AB (publ) appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio3.74
Quick ratio--
Total debt/total equity0.0519
Total debt/total capital0.0494
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.